{
    "title": "U.S. FDA approves Bristol-Myers MS drug, launch delayed due to coronavirus",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8155421/U-S-FDA-approves-Bristol-Myers-MS-drug-coronavirus-delay-launch.html",
    "date": "2020-03-26",
    "keywords": [
        "drug",
        "company",
        "sclerosis",
        "approval",
        "co",
        "treatment",
        "celgene",
        "year",
        "deal",
        "quarter",
        "thursday",
        "food",
        "administration",
        "ms",
        "zeposia",
        "launch",
        "coronavirus",
        "ozanimod",
        "portfolio",
        "acquisition",
        "payout",
        "part",
        "contingent",
        "value",
        "share",
        "highprofile",
        "pipeline",
        "march",
        "delay",
        "market",
        "blockbuster",
        "novartis",
        "pharma",
        "mayzent",
        "function",
        "disease",
        "immune",
        "system",
        "myelin",
        "sheath",
        "migration",
        "blood",
        "brain",
        "spinal",
        "cord",
        "reason",
        "affect",
        "mechanism",
        "growth",
        "driver",
        "cancer",
        "pressure",
        "merck",
        "amp",
        "keytruda",
        "mark",
        "access",
        "companys",
        "cash",
        "cow",
        "revlimid",
        "patent",
        "expiration",
        "spokeswoman",
        "price",
        "trading",
        "bell",
        "reporting",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}